Skip to main content
. 2021 Oct 6;9(12):916–924. doi: 10.1016/j.jchf.2021.07.003

Table 1.

Baseline Characteristics After Matching

In-Person Visits (n = 4,541) Telehealth Visits (n = 4,541) P Value
Year of visit <0.001
 2018 2,325 (51.2) 0 (0.0)
 2019 2,216 (48.8) 0 (0.0)
 2020 0 (0.0) 4,541 (100.0)
Provider type 0.316
 Physician 2,891 (63.7) 2,845 (62.7)
 Advanced practice provider 1,650 (36.3) 1,696 (37.3)
Heart failure provider 1,287 (28.3) 1,365 (30.1) 0.071
Scheduled within 48 h of visit date 667 (14.7) 651 (14.3) 0.633
Age, y 71.1 ± 13.8 70.8 ± 14.0 0.311
Male 2,495 (54.9) 2,474 (54.5) 0.657
Race 0.807
 White 3,742 (82.4) 3,712 (81.7)
 Black 682 (15.0) 700 (15.4)
 Asian 21 (0.5) 22 (0.5)
 Other 96 (2.1) 107 (2.4)
Hispanic ethnicity 94 (2.1) 102 (2.3) 0.549
Payer source 0.039
 Medicare 2,195 (48.6) 2,113 (46.9)
 Commercial 2,049 (45.4) 2,048 (45.5)
 Medicaid 194 (4.3) 251 (5.6)
 Other government 24 (0.5) 31 (0.7)
 Self-pay 54 (1.2) 60 (1.3)
Acute heart failure 262 (5.8) 269 (5.9) 0.754
Systolic heart failure 1,982 (43.6) 2,032 (44.7) 0.290
Hypertension 3,821 (84.1) 3,836 (84.5) 0.665
Diabetes 2,039 (44.9) 2,089 (46.0) 0.292
Hyperlipidemia 3,005 (66.2) 2,973 (65.5) 0.478
Chronic kidney disease stage ≥3 1,459 (32.1) 1,511 (33.3) 0.244
Coronary artery disease 2,437 (53.7) 2,367 (52.1) 0.141
Prior MI, PCI, or CABG 1,652 (36.4) 1,643 (36.2) 0.844
Prior stroke 456 (10.0) 468 (10.3) 0.677
Atrial fibrillation 2,036 (44.8) 2,019 (44.5) 0.719
Prior ventricular tachycardia 897 (19.8) 891 (19.6) 0.874
Implantable cardioverter defibrillator 1,079 (23.8) 1,043 (23.0) 0.372

Values are n (%) or mean ± SD.

CABG = coronary artery bypass graft; MI = myocardial infarction, PCI = percutaneous coronary intervention.